Full Text
PNS243 REVIEW OF PATIENT REPORTED OUTCOME (PRO) MEASURES FOR NOVEL DRUG APPROVALS (NDA) IN THE UNITED STATES: 2016-2018

Abstract

Authors

Y.E. Shin S.B. Kim Z. Zheng J. Muzumdar W. Wu

Back to Volume 22, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×